Bridgepoint Group plc (BPT.L)
London, GB
Bridgepoint Group plc, formerly Bridgepoint Group Limited, is a financial institution specializing in both private equity and private credit. The firm deploys capital across diverse investment strategies, including growth capital, buyouts, syndicated debt, infrastructure financing, direct lending, and various private credit opportunities. It targets companies ranging from lower mid-market and middle market to small mid-cap and small-cap segments. Bridgepoint's investment focus spans a wide array of sectors. These include advanced industrials, automation, agricultural sciences, and businesses facilitating the energy transition. It also actively invests in business services, financial services, professional services, testing, inspection, and certification (TIC), and information services. Within the consumer domain, the firm backs digital brands, video games, and wellbeing products. Additionally, Bridgepoint has a significant presence in healthcare, particularly in pharmaceuticals, Med-Tech products, and outsourced Med-Tech services. Geographically, the firm primarily seeks opportunities across the United Kingdom, New York, Germany, Austria, Switzerland, Spain, France, and the Nordic region. Equity investments generally range from £4.77 million (approximately $5.91 million) to €300 million (around $348.8 million). Specifically, commitments for small mid-cap companies are typically between £40 million ($49.54 million) and £125 million ($154.82 million), while small-cap investments are usually between £10 million ($12.39 million) and £25 million ($30.96 million). Bridgepoint focuses on businesses with an enterprise value ranging from €10 million (about $10.74 million) to €1 billion (approximately $1.07 billion). Established in 1985, Bridgepoint Group plc is headquartered in London, United Kingdom, and maintains a global operational presence with additional offices across North America, Asia, and Europe.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.12% | +0.97% | +7.91% | +7.14% | -4.59% | -4.86% | -6.83% | +23.63% | -40.27% | -40.27% | +13.80% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 4 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Asset Management: +17.4%+22.8% ★ Q4'25: +36.7% (vs Q4'23)
-
EPS growth Asset Management: +22.7%-23.7% Q4'25: -78.4% (vs Q4'23)
-
FCF margin FCF growth · Asset Management: +27.7%+26.7% ★ Q4'25: +38.5% (vs Q4'23)
-
EBIT margin Asset Management: +50.6%+25.6% Q4'25: +17.8% (vs Q4'23)
-
ROIC Asset Management: +6.5%— Q4'25: -7.1% (vs Q4'23)
-
Share dilution Asset Management: +0.0%-16.1% ★ Q4'25: +11.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Asset Management: -0.03×2.93× ★ Q4'25: 1.78× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
212.00M
est: 247.49M (-14.3%)
|
265.70M
est: 298.44M (-11.0%)
|
295.30M
est: 342.10M (-13.7%)
|
388.30M
est: 486.39M (-20.2%)
|
476.70M
est: 566.82M (-15.9%)
|
648.09M
607.59M – 683.47M
+14.3% YoY
|
731.07M
688.48M – 778.68M
+12.8% YoY
|
763.96M
762.06M – 765.86M
+4.5% YoY
|
| EBITDA |
112.80M
est: 112.98M (-0.2%)
|
150.40M
est: 136.24M (+10.4%)
|
110.00M
est: 151.75M (-27.5%)
|
138.00M
est: 215.75M (-36.0%)
|
186.80M
est: 251.43M (-25.7%)
|
287.48M
269.51M – 303.17M
+14.3% YoY
|
324.29M
305.40M – 345.40M
+12.8% YoY
|
338.88M
338.03M – 339.72M
+4.5% YoY
|
| EBIT |
97.80M
est: 94.66M (+3.3%)
|
132.10M
est: 114.14M (+15.7%)
|
91.30M
est: 122.17M (-25.3%)
|
101.80M
est: 173.70M (-41.4%)
|
121.90M
est: 202.42M (-39.8%)
|
231.44M
216.98M – 244.08M
+14.3% YoY
|
261.07M
245.87M – 278.07M
+12.8% YoY
|
272.82M
272.14M – 273.50M
+4.5% YoY
|
| Net Income |
57.80M
est: 75.82M (-23.8%)
|
120.60M
est: 123.90M (-2.7%)
|
70.70M
est: 65.60M (+7.8%)
|
64.80M
est: 159.45M (-59.4%)
|
41.50M
est: 172.24M (-75.9%)
|
218.08M
208.73M – 227.42M
+26.6% YoY
|
261.51M
239.92M – 283.10M
+19.9% YoY
|
291.61M
232.71M – 313.45M
+11.5% YoY
|
| SGA |
200.0K
est: 892.8K (-77.6%)
|
300.0K
est: 1.08M (-72.1%)
|
1.90M
est: 987.3K (+92.4%)
|
2.30M
est: 1.40M (+63.9%)
|
—
est: 1.64M (-100.0%)
|
1.87M
1.75M – 1.97M
+14.3% YoY
|
2.11M
1.99M – 2.25M
+12.8% YoY
|
2.20M
2.20M – 2.21M
+4.5% YoY
|
| EPS |
0.07
est: 0.07 (-5.6%)
|
0.15
est: 0.13 (+19.8%)
|
0.09
est: 0.08 (+6.2%)
|
0.08
est: 0.19 (-56.9%)
|
0.05
est: 0.20 (-74.3%)
|
0.25
0.24 – 0.27
+30.4% YoY
|
0.30
0.28 – 0.33
+19.5% YoY
|
0.30
0.27 – 0.37
+0.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck Alternative Asset Manager ETF GPZ | 1.97% | 4.59M | 0.40% |
| 2 | Amundi Prime UK Mid & Small Cap UCITS ETF DR - GBP (D) PRUK.L | 1.02% | 4.35M | 0.05% |
| 3 | WisdomTree UK Quality Dividend Growth UCITS ETF - GBP UGRW.L | 0.54% | 58.9K | 0.29% |
| 4 | Invesco FTSE 250 UCITS ETF S250.L | 0.52% | 183.9K | 0.12% |
| 5 | iShares FTSE 250 UCITS ETF MIDD.L | 0.51% | 4.33M | 0.40% |
| 6 | HSBC FTSE 250 UCITS ETF HMCX.L | 0.50% | 337.7K | 0.09% |
| 7 | Xtrackers FTSE 250 UCITS ETF 1D XMCX.L | 0.49% | 189.1K | 0.15% |
| 8 | Vanguard FTSE 250 UCITS ETF VMIG.MI | 0.47% | 12.39M | 0.10% |
| 9 | Vanguard FTSE 250 UCITS ETF (GBP) Distributing VMID.DE | 0.47% | 12.39M | 0.10% |
| 10 | iShares STOXX Europe 600 Financial Services UCITS ETF (DE) EXH2.DE | 0.45% | 505.6K | 0.46% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jonathan Raoul Hughes | Chief Executive | 2M | male |
| Ruth Catherine Prior | Group CFO, Partner & Director | 2M | female |
| Ayaz Khan | Director of Bridgepoint Credit | — | male |
| Bertrand Demesse | Partner & Head of BDC France | — | male |
| Bowles | Director | — | female |
| Carlota Sanchez-Marco | Partner & Head of Credit Investor Services | — | female |
| Douglas W. Kimmelman | ECP Executive Chairman & ECP Founder | — | male |
| Dominik Mattmann | Partner & Head of Portfolio Optimisation | — | male |
| Duncan Richard Calam | Partner & Head of Bridgepoint Growth | — | male |
| Hamish Grant | Head of Investor Services | — | male |
| Jamie Lucas | Chief Operating Officer of Credit | — | male |
| Benoît Alteirac | Partner | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BPT.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
